IC2000
Lymph Node Mapping
Novadaq Technologies ULC, now a part of StrykerPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Lymph Node Mapping cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TECHNETIUM TC 99M SULFUR COLLOID Novadaq Technologies ULC, now a part of Stryker | Phase 3 | B |
Indocyanine Green Isabelle Henskens | N/A | D |
TECHNETIUM, TC-99M Isabelle Henskens | N/A | D |
Same molecule, other indications
IC2000 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →